| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
48,058,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Baltimore David |
Director |
– • – |
2019-04-02 |
4 |
D |
$5.85 |
$457,979 |
D/D |
(78,287) |
0 |
|
- |
|
| Berger Franklin M |
Director |
– • – |
2019-04-02 |
4 |
D |
$5.85 |
$438,750 |
D/D |
(75,000) |
0 |
|
- |
|
| Gombotz Wayne |
Chief Development Officer |
• – – |
2019-04-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(37,068) |
0 |
|
- |
|
| Yurasov Sergey |
Sr. VP, Clinic. Devel. & CMO |
• – – |
2019-04-02 |
4 |
D |
$5.85 |
$35,896 |
D/D |
(6,136) |
0 |
|
- |
|
| Brady Stephen R |
EVP, Strategy & Finance |
• – – |
2019-04-02 |
4 |
D |
$5.85 |
$99,819 |
D/D |
(17,063) |
0 |
|
- |
|
| Paya Carlos V |
President and CEO |
• • – |
2019-04-02 |
4 |
D |
$5.85 |
$208,120 |
D/D |
(35,576) |
0 |
|
- |
|
| Coleman Lewis W |
Director |
– • – |
2019-04-02 |
4 |
D |
$5.85 |
$1,041,300 |
I/I |
(178,000) |
0 |
|
- |
|
| Ter Meulen Jan Henrik |
Chief Scientific Officer |
• – – |
2019-04-02 |
4 |
D |
$5.85 |
$85,527 |
D/D |
(14,620) |
0 |
|
- |
|
| Svennilson Peter |
Managing Partner |
– – • |
2019-04-02 |
4 |
D |
$5.85 |
$38,861,211 |
D/D |
(6,642,942) |
0 |
|
- |
|
| Paya Carlos V |
President and CEO |
• • – |
2019-01-07 |
4 |
AS |
$1.58 |
$20,591 |
D/D |
(13,014) |
156,576 |
|
- |
|
| Brady Stephen R |
EVP, Strategy & Finance |
• – – |
2019-01-07 |
4 |
AS |
$1.58 |
$8,722 |
D/D |
(5,516) |
96,599 |
|
- |
|
| Ter Meulen Jan Henrik |
Chief Scientific Officer |
• – – |
2019-01-07 |
4 |
AS |
$1.59 |
$5,415 |
D/D |
(3,414) |
83,982 |
|
- |
|
| Yurasov Sergey |
Sr. VP, Clinic. Devel. & CMO |
• – – |
2019-01-07 |
4 |
AS |
$1.57 |
$5,536 |
D/D |
(3,522) |
78,756 |
|
- |
|
| Paya Carlos V |
President and CEO |
• • – |
2019-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
63,000 |
169,590 |
|
- |
|
| Brady Stephen R |
EVP, Strategy & Finance |
• – – |
2019-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
102,115 |
|
- |
|
| Ter Meulen Jan Henrik |
Chief Scientific Officer |
• – – |
2019-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
87,396 |
|
- |
|
| Yurasov Sergey |
Sr. VP, Clinic. Devel. & CMO |
• – – |
2019-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
82,278 |
|
- |
|
| Lampert Mark N |
10% Owner |
– – • |
2018-12-04 |
4 |
S |
$1.83 |
$1,653,907 |
D/D |
(902,000) |
370,391 |
|
- |
|
| Yurasov Sergey |
Sr. VP, Clinic. Devel. & CMO |
• – – |
2018-11-07 |
4 |
A |
$0.00 |
$0 |
D/D |
29,953 |
57,278 |
|
- |
|
| Brady Stephen R |
EVP, Strategy & Finance |
• – – |
2018-11-07 |
4 |
A |
$0.00 |
$0 |
D/D |
29,953 |
77,115 |
|
- |
|
| Ter Meulen Jan Henrik |
Chief Scientific Officer |
• – – |
2018-11-07 |
4 |
A |
$0.00 |
$0 |
D/D |
23,362 |
62,396 |
|
- |
|
| Guthart Leo |
10% Owner |
– – • |
2018-01-08 |
4/A |
B |
$3.90 |
$78,000 |
I/I |
20,000 |
5,664,739 |
1.5 |
- |
|
| Yurasov Sergey |
Sr. VP, Clinic. Devel. & CMO |
• – – |
2018-01-05 |
4/A |
AS |
$4.17 |
$2,816 |
D/D |
(675) |
27,325 |
|
- |
|
| Ter Meulen Jan Henrik |
Chief Scientific Officer |
• – – |
2018-01-05 |
4 |
AS |
$4.17 |
$8,282 |
D/D |
(1,986) |
39,034 |
|
- |
|
| Gombotz Wayne |
Chief Development Officer |
• – – |
2018-01-05 |
4 |
AS |
$4.17 |
$8,282 |
D/D |
(1,986) |
37,068 |
|
- |
|
122 Records found
|
|
Page 1 of 5 |
|
|
